Edwards Lifesciences Corp. (EW)
-NYSE | Prev Close: | 65.72 |
|---|
| Open: | N/A |
|---|
| Bid: | 64.01 x 100 |
|---|
| Ask: | 69.24 x 100 |
|---|
| 1y Target Est: | 77.61 |
|---|
| Beta: | 0.62 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 62.34 - 110.79 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 1,442,520 |
|---|
| Market Cap: | 7.42B |
|---|
| P/E (ttm): | 20.78 |
|---|
| EPS (ttm): | 3.16 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Edwards Life Sciences Corp. (EW): Today's Featured Health Care Winnerat TheStreet(Fri, 05:00 SGT)
- Promising Data on Edwards' Sapien XTZacks(Fri, 02:00 SGT)
- Today's Stocks Driving Success For The Health Services Industryat TheStreet(Fri, 01:03 SGT)
- Boston Scientific’s Lotus Aortic Valve Has Promise in Studyat Bloomberg(Thu, 23 May)
- Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter ValveMarketwired(Tue, 21 May)
- Medtronic’s Heart Rhythm Devices Show Signs of Growthat Bloomberg(Tue, 21 May)
- Sony, SodaStream, Trina Solar are big moversAP(Wed, 15 May)
- Edwards board OKs buyback of $750 million in stockAP(Tue, 14 May)
- Edwards Lifesciences tumbles on 1Q Sapien salesAP(Thu, 25 Apr)
- Edwards Lifesciences cuts heart valve sales viewAP(Wed, 24 Apr)
Key Statistics
| Forward P/E (1 yr): | 18.05 |
|---|
| P/S (ttm): | 3.83 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.05 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.76 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.49 |
|---|
Business Summary
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products,...
View More